Location History:
- San Diego, CA (US) (2001)
- Seattle, WA (US) (2003)
Company Filing History:
Years Active: 2001-2003
Title: Scott M Glaser: Innovator in Antibody Technology and High Throughput Isolation Methods
Introduction
Scott M Glaser is a notable inventor based in Seattle, Washington. He has made significant contributions to the fields of biotechnology and molecular biology, particularly through his innovative patents. With a total of two patents to his name, Glaser's work focuses on advancements in antibody technology and methods for isolating periplasmic fractions from cells.
Latest Patents
One of Glaser's latest patents is titled "Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same." This invention provides a Vitaxin antibody and a LM609 grafted antibody that exhibit selective binding affinity to α and β. The Vitaxin antibody consists of at least one Vitaxin heavy chain polypeptide and at least one Vitaxin light chain polypeptide or functional fragments thereof. Additionally, the patent includes nucleic acids encoding the Vitaxin and LM609 grafted heavy and light chains, as well as nucleic acids encoding the parental non-human antibody LM609.
Another significant patent by Glaser is for a "Vacuum device and method for isolating periplasmic fraction from cells." This high throughput device allows for the simultaneous isolation of periplasmic fractions from multiple samples of host cells. The method involves providing a high throughput device, applying a vacuum, and removing the outer membrane of the host cells to collect the periplasmic fractions efficiently.
Career Highlights
Scott M Glaser is associated with Ixsys, Incorporated, where he continues to contribute to innovative research and development. His work has been instrumental in advancing techniques that enhance the efficiency of antibody production and cellular fraction isolation.
Collaborations
Glaser has collaborated with notable colleagues, including William D Huse and William P MacConnell. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the field of biotechnology.
Conclusion
Scott M Glaser's contributions to antibody technology and high throughput isolation methods highlight his role as a significant inventor in the biotechnology sector. His innovative patents reflect a commitment to advancing scientific knowledge and improving methodologies in molecular biology.